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Leprosy is a neglected tropical disease predominately affecting poor and marginalized populations. To test the
hypothesis that poverty-alleviating policies might be associated with reduced leprosy incidence, we evaluated
the association between the Brazilian Bolsa Familia (BFP) conditional cash transfer program and new leprosy
case detection using linked records from 12,949,730 families in the 100 Million Brazilian Cohort (2007–2014).
After propensity score matching BFP beneficiary to nonbeneficiary families, we used Mantel-Haenszel tests and
Poisson regressions to estimate incidence rate ratios for new leprosy case detection and secondary endpoints
related to operational classification and leprosy-associated disabilities at diagnosis. Overall, cumulative leprosy
incidence was 17.4/100,000 person-years at risk (95% CI: 17.1, 17.7) and markedly higher in “priority” (high-
burden) versus “nonpriority” (low-burden) municipalities (22.8/100,000 person-years at risk, 95% confidence
interval (CI): 22.2, 23.3, compared with 14.3/100,000 person-years at risk, 95% CI: 14.0, 14.7). After matching,
BFP participation was not associated with leprosy incidence overall (incidence rate ratio (IRR)Poisson = 0.97,
95% CI: 0.90, 1.04) but was associated with lower leprosy incidence when restricted to families living in high-
burden municipalities (IRRPoisson = 0.86, 95% CI: 0.77, 0.96). In high-burden municipalities, the association was
particularly pronounced for paucibacillary cases (IRRPoisson = 0.82, 95% CI: 0.68, 0.98) and cases with leprosy-
associated disabilities (IRRPoisson = 0.79, 95% CI: 0.65, 0.97). These findings provide policy-relevant evidence
that social policies might contribute to ongoing leprosy control efforts in high-burden communities.
Bolsa Familia Program; cash transfers; Hansen’s disease; inequality; infectious diseases; poverty
Abbreviations: BRL, Brazilian reals; BFP, Bolsa Familia Program; CadUnico, Brazilian National Registry for Social Programs
Cadastro Único; CCT, conditional cash-transfers; CI, confidence interval; IRR, incidence rate ratio; MB, multibacillary; MH,
Mantel-Haenszel; PB, paucibacillary; PS, propensity score; SINAN, Brazilian Notifiable Disease Registry.
Leprosy is a neglected tropical disease that can lead to
blindness and permanent disabilities if left untreated. While
the prevalence of leprosy has declined over the last 30 years,
leprosy continues to be an important cause of disability and
stigma among the over 200,000 individuals diagnosed annu-
ally worldwide (1, 2). There is an increasing recognition that
leprosy and other neglected tropical diseases are strongly
linked to poverty, being both attributable to and responsible
for unfavorable economic conditions in affected populations
(3–5).
Conditional cash transfer programs (CCTs) have been
proposed as a promising, cost-effective strategy for over-
coming intergenerational poverty and ameliorating the
social determinants of health (6). However, there is limited
evidence of their impact on neglected tropical diseases
(7). The Brazilian CCT, the Bolsa Familia Program (BFP),
provides financial aid to low-income families, conditional on
school attendance and preventive health checkups, and has
been linked to improvements in children’s education, health-
care access, and food security (8–12). Although leprosy in
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Brazil has been declining in the past decades, Brazil still
registers over 20,000 new leprosy cases annually, accounting
for over 14% of cases diagnosed globally (13). Higher CCT
coverage has been associated with reductions in leprosy risk
at the population level (14, 15). However, no studies to date
have provided a robust assessment of the impact of BFP or
any CCTs on the burden of leprosy using individual-level
data. (11)
To address this gap, we tested the hypothesis that receiv-
ing BFP can reduce leprosy incidence, using prospective
data that was routinely collected from families enrolled in
the Brazilian National Registry for Social Programs Cadas-
tro Único (CadUnico), the BFP Payroll Database, and the
Brazilian Notifiable Disease Registry (SINAN), and linked
as part of the 100 Million Brazilian Cohort.
METHODS
Intervention
The BFP targets families registered in CadUnico who
live in: 1) extreme poverty (i.e., earning ≤60 Brazilian Real
(BRL) per capita/month in 2007–2008 and ≤70 BRL per
capita/month in 2009–2014); or 2) poverty (i.e., ≤120 BRL
per capita/month in 2007–2008 and ≤140 BRL per capita/
month in 2009–2014) with ≥1 child (i.e., <18 years old)
and/or with a woman who is pregnant or breastfeeding (Web
Appendix 1, Web Tables 1–8, available at https://academic.
oup.com/aje). One BRL = approximately 0.25 US dollars.
The BFP provides monthly payments to families conditional
on compliance with: 1) children’s attendance for ≥80% of
school days; 2) health monitoring of children ≤6 years of
age and breastfeeding women; and 3) prenatal care (see Web
Appendix 1 for further details).
Data sources and linkage
The 100 Million Brazilian Cohort is a large-scale linked
cohort that aims to evaluate the impact of the BFP and
other social programs on health outcomes in Brazil (16). For
the current investigation, we linked the baseline of the 100
Million Brazilian Cohort, the BFP Payroll Database (2004–
2015), and SINAN (2007–2014) (17). See Web Appendix 2
for linkage details.
The 100 Million Brazilian Cohort baseline covariates
comprised those from the first registry of families in
CadUnico: sociodemographic variables (i.e., sex, age, self-
identified race/ethnicity, education, and work) for the head
of family (i.e., oldest member), the state and area of
residence (urban vs. rural), household living conditions
(i.e., house ownership, housing material, water supply,
electricity, sewage, and waste collection), per capita income,
and individual-level identifiers for linkage (i.e., Social
Identification Number (NIS), name, date of birth, sex,
maternal name, and municipality). Exposure data extracted
from the BFP Payroll Database included starting and end
dates of BFP benefit receipt for each primary recipient
per family and the individual-level identifier for linkage
(i.e., Social Identification Number). Outcome data extracted
from SINAN included: date of leprosy diagnosis, clinical
presentation (i.e., paucibacillary (PB): ≤5 lesions; or
multibacillary (MB): >5 lesions or positive slit skin smear),
and disabilities at diagnosis (i.e., grade 0 if no disabilities or
grade 1/2 with any sign of eye problems, visible deformity,
damage, or anesthesia in hands and feet) (2), and individual-
level identifiers for linkage (i.e., name, date of birth, sex,
maternal name, and municipality).
The 100 Million Brazilian Cohort baseline and BFP data
sets were deterministically linked using a unique identifier
(i.e., Social Identification Number). The cohort baseline and
SINAN data sets were linked by the 5 individual-level iden-
tifiers in 2 steps using the CIDACS-RL tool (https://gitHub.
com/gcgbarbosa/cidacs-rl) (16). In the first step, entries
were deterministically linked. In the second step, entries that
were not linked deterministically were then linked based
on a similarity score between all the pairwise comparisons
(i.e., ranging from 0 to 1); entries with the highest similarity
scores were considered to be linked pairs.
To assess the accuracy of the linkage procedures, we
performed a manual validation study; 10,000 pairs were
randomly selected from all possible paired links. Manual
verification was used to classify pairs as true or false links.
Various cutoffs of the similarity score were used to declare
pairs to be a link. These linkages were compared with the
true link status to determine the sensitivity and specificity at
each potential cutoff. The cutoff corresponding to the opti-
mal sensitivity and specificity was chosen (a similarity score
of 0.92) to determine links for this study (Web Appendix 2)
(18). Following linkage, individual identifiers were removed
from the data set.
Selection of the study population
The study population included individuals belonging to
families who enrolled in the 100 Million Brazilian Cohort
between January 2007 and December 2014. We excluded
families who: 1) lacked at least 1 individual over 15 years
of age at enrollment (i.e., children recorded separately from
an adult caregiver were not considered to be a family); 2)
had a monthly per capita income exceeding 5,000 BRL;
and/or 3) started receiving BFP benefits prior to enrollment.
We defined as BFP beneficiary families those that started
receiving BFP benefits within 6 months after enrollment
in the cohort (i.e., reflecting the typical time to receipt for
families who would eventually become beneficiaries) and
nonbeneficiary families (i.e., non-BFP) those that did not
start receiving the benefit within 6 months after enrollment
(Web Figure 1). We analyzed the overall sample and then
stratified our study population by whether or not families
resided in one of the 182 “priority” municipalities in Brazil
as officially designated due to their high burden of leprosy
(Figure 1) (19).
Statistical analysis
Propensity score matching. We used propensity score (PS)
matching to compare BFP beneficiary (i.e., exposed) and
nonbeneficiary (i.e., unexposed) families. We estimated the
Am J Epidemiol. 2020;189(12):1547–1558
Conditional Cash Transfer Program and Leprosy Incidence 1549
Figure 1. Map of Brazil, showing the priority municipalities for leprosy control in Brazil designated as high-burden (A) and the proportion of
individuals residing in high-burden municipalities according to state (B) for the 26 Brazilian states and the Brazilian Federal District, 2016. High-
burden municipalities include all state capitals, municipalities in high-risk areas for leprosy with a leprosy new-case detection rate ≥20/100,000
or ≥20 new cases or ≥10 new cases, with at least 1 case in children under age 15 years in 2010, and municipalities outside the geographical
risk areas with ≥50 new cases, with at least 5 cases in children under 15 years of age in 2010.
PS by multiple logistic regression using baseline sociode-
mographic characteristics and year of application for each
data set (i.e., overall sample, high-burden municipalities,
and low-burden municipalities) (Web Figure 1). Missingness
in PS covariates was considered as a category. We per-
formed 1:1 nearest-neighbor matching with a caliper of 0.05,
allowing a same nonbeneficiary family to match with more
than 1 beneficiary family (i.e., matching with replacement)
(20). We compared the difference in the distribution of PS
covariates between beneficiary and nonbeneficiary families
using the standardized mean difference to assess balance of
potential confounders before and after matching (standard-
ized mean difference of >0.1 was taken to indicate potential
confounding by that characteristic) (21). See Web Appendix
3 for matching details.
Primary and secondary outcome analysis. Incident cases
were defined as the first newly detected case of leprosy
occurring within family units after enrollment. Secondary
endpoints for leprosy incidence included operational classi-
fication (i.e., PB and MB) and the presence of disabilities
at diagnosis (i.e., grade 0 and grade 1/2). Families with a
leprosy case diagnosed prior to or within the first 6 months
after enrollment were not considered disease-free at baseline
and were therefore excluded from the analyses. For family
units with more than 1 case occurring during the study
period, only the first case was considered in the analysis.
Family-years at risk began 6 months after enrollment (i.e.,
the time at which exposure status was determined) and ended
on December 31, 2014, or at diagnosis of the first new
leprosy case in the family. The total person-years at risk for
each family was defined as the contribution of each family-
year at risk multiplied by the number of individuals in the
family. Unexposed families who later participated in BFP
were censored at the time they started receiving BFP ben-
efits. Given that the potential benefits of BFP participation
(e.g., via behavior changes associated with the conditional-
ities) could persist after families stopped receiving the cash
transfer benefit itself, BFP-exposed families remained in the
exposed group during the full study period. For analyses
of secondary endpoints, families were censored at the first
new leprosy diagnosis if that diagnosis was an operational
classification/grade of disabilities other than the one being
considered or if it was missing.
We estimated the incidence rate ratios of leprosy new-case
detection rate in the family (i.e., familial detection rate) in
the matched cohort using Mantel-Haenszel (MH) tests and
Poisson regressions with further adjustment for per capita
income and robust standard errors clustered by family to
account for matching with replacement. The person-years
at risk were included in the model as an offset variable. We
estimated the cumulative incidence rate ratio for beneficiary
and nonbeneficiary families of BFP over time using the
Nelson-Aalen estimator (22, 23). In addition, we estimated
the association of BFP participation and familial detection
rate of leprosy using Poisson regression models stratified
by duration of follow-up (i.e., 0–6 months of exposure,
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6 months and 1 day to 12 months, 1 year and 1 day to 2
years, 2 years and 1 day to 3 years, and >3 years).
Sensitivity analyses. To account for the possibility that
some individuals might have started receiving BFP after
the sixth month, we also analyzed BFP as a time-varying
exposure. In this analysis, families that started receiving
BFP between 6 months and 1 year after registration in
CadUnico switched to the exposed group from 1 year on
and were matched to families who had not received BFP
by 1 year; similarly, families receiving by 1 year and 1
day to 2 years, and by 2 years and 1 day to 3 years,
switched to the exposed group and were matched to families
remaining unexposed (see Web Appendix 4, Web Figure 1).
To explore the robustness of our results to the way income
was accounted for, because this is an important factor due
to being the main eligibility criterion for BFP, we excluded
income from the Poisson regression model and adjusted
for income using restricted cubic splines. Additionally, we
estimated the association of BFP using inverse probability of
treatment weighting and restricted the analysis to complete
cases (i.e., excluding participants with missing data for
any covariate in the PS model) (Web Appendix 5). To test
whether there were potential biases due to differential loss of
follow-up between BFP and non-BFP beneficiary families,
we censored each matched pair by the smallest contribution
of family-years at risk for them to contribute to the same
number of family-years at risk. Finally, to test whether there
was competing risk bias due to lack of mortality information
in our cohort, we limited the follow-up time of each matched
pair to 2 years.
All analyses were performed using STATA, version 15.0
(StataCorp LLC, College Station, Texas), and R, version
3.5.2 (R Foundation for Statistical Computing, Vienna, Aus-
tria) (packages: dplyr, brmap, descr, ggplot2, ggthemes,
gridExtra, grid, readxl, reshape2, and ggfortify).
This study was performed under the international
(Helsinki), Brazilian, and UK research regulations and was
approved by the research ethics committee of 3 institutions:
University of Brasília (1.822.125), Instituto Gonçalo Muniz-
Fiocruz (1.612.302), and London School of Hygiene and
Tropical Medicine (10580–1).
RESULTS
Of the 37,285,406 individuals in the 100 Million Brazil-
ian Cohort who registered to CadUnico between 2007 and
2014, 31,613,355 individuals from 12,949,730 families were
investigated in this study (Figure 2). From this sample, we
identified 44,074 new leprosy cases among families in the
cohort baseline between 2007 and 2014. This represents
94% (44,074/46,856) of the number of cases expected if the
cohort had similar leprosy incidence to the whole Brazilian
population and 15.6% of the cases diagnosed in Brazil in the
same period (Web Appendix 2, Web Table 1). After enroll-
ment in the cohort, 4,328,630 commenced BFP participation
within 6 months and an additional 2,865,583 of the included
families started BFP benefits after that period. Among the
4,459,239 families living in high-burden leprosy municipal-
ities, 41.9% (1,868,116/4,459,239) started benefiting from
BFP within 6 months; among the 8,490,491 families living
in low-burden municipalities, 29.0% (2,460,514/8,490,491)
started receiving BFP benefits within the same period.
Overall, leprosy cases were detected in 43,651 families in
the cohort, of which 22,301 occurred after enrollment. Over
the study period, from 2007–2014, leprosy incidence rates
remained constant in BFP beneficiary and non-BFP benefi-
ciary families from our cohort (Web Appendix 6, Web Figure
2). Out of the 22,301 incident cases, 8,622 (38.7%) cases
were classified as PB, 13,661 (61.3%) as MB, and 18 (0.1%)
as missing data on operational classification. Of cases,
13,777 (61.8%) were diagnosed without disabilities, 6,290
(28.2%) were diagnosed with leprosy-associated disabilities
(grade 1/2), and for 2,234 cases (10.0%) grade of disabilities
was not recorded. Overall, the familial detection rate was
17.4/100,000 person-years at risk (95% confidence interval
(CI): 17.1, 17.7) and substantially higher in “priority”
(high-burden) compared with “nonpriority” (low-burden)
municipalities (familial detection rate = 22.8/100,000, 95%
CI: 22.2, 23.3, vs. familial detection rate = 14.3/100,000,
95% CI: 14.0, 14.7). Crude cumulative leprosy incidence
among families was markedly lower among BFP than among
non-BFP beneficiaries (crude relative risk (RR)MH = 0.70,
95% CI: 0.68, 0.73), with similar differences in high-burden
(crude RRMH = 0.62, 95% CI: 0.59, 0.65) and in low-burden
municipalities (crude RRMH = 0.69, 95% CI: 0.66, 0.72)
(Figure 3A–C).
At baseline, there were significant differences between
families who received BFP benefits (hereafter, BFP) and
those that did not (hereafter, non-BFP) (Table 1). Relative to
non-BFP participants, BFP family heads were more likely
to be female (60.7% vs. 53.4%) and were younger (median
age 32.6 vs. 40.2 years). BFP families also had relatively
higher median numbers of individuals per family (3 vs. 2),
and lower median monthly per capita income (50.0 BRL vs.
177.7 BRL, equivalent to 6.9% and 24.5% of the 2014 min-
imum wage). PS matching successfully matched >99.9%
of the BFP families with similar non-BFP families in all
matched samples (See Web Appendix 3, Web Figures 3–4,
and Web Tables 4–5 for details of the PS analysis).
After matching, using Mantel-Haenszel tests or Poisson
regression models with further adjustment for income,
BFP was not associated with lower familial detection
rate of leprosy in our overall sample (incidence rate ratio
(IRR)MH = 0.96, 95% CI: 0.92, 1.00; IRRPoisson = 0.97,
95% CI: 0.90, 1.04), but BFP beneficiary families living
in high-burden municipalities had a substantially lower
familial detection rate of leprosy (IRRPoisson = 0.86, 95%
CI: 0.77, 0.96) (Table 2). In high-burden municipalities, the
point estimates for the association between BFP and leprosy
was more extreme for the detection of leprosy-associated
disabilities (IRRPoisson = 0.79, 95% CI: 0.65, 0.97) and
paucibacillary cases (IRRPoisson = 0.82, 95% CI: 0.68, 0.98).
The cumulative familial detection rate of leprosy was ini-
tially similar between beneficiary and nonbeneficiary fami-
lies (Figure 3C and 3D). However, after 2 years, the accrual
of new cases detected was markedly lower among benefi-
ciary families, and the difference in familial detection rate
according to exposure status was larger among the families
living in high-burden municipalities (Figure 3D). Also, by
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Figure 2. Flowchart of the study population, Brazil, 2001–2015. BRL, Brazilian reals; BFP, Bolsa Familia Program; CadUnico, Brazilian National
Registry for Social Programs Cadastro Único.
using Poisson models stratified temporally, the point esti-
mate for the association between BFP receipt and leprosy
familial detection rate indicated slightly higher detection in
the first 6 months on benefits but lower familial detection
rate thereafter (Web Table 5 and Web Figure 5). Similar
trends were observed for secondary endpoints related to
grade of disabilities, but no differences over time were
observed according to operational classification (Web Table
5 and Web Figure 5).
In sensitivity analysis, when allowing treatment to vary
over time, we obtained similar but less extreme point esti-
mates for the association between BFP and leprosy pri-
mary endpoints (Web Table 6). We also obtained similar
point estimates for the association between receiving BFP
and familial detection rate of leprosy when using Poisson
regression without further adjusting for income (IRRPoisson =
0.96, 95% CI: 0.89, 1.03) and when further adjusting for
income using spline (IRRPoisson = 0.93, 95% CI: 0.87, 1.00)
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Figure 3. Cumulative incidence of leprosy among families (per 100,000) defined as receiving Bolsa Familia Program benefits within 6 months
of enrollment in our cohort baseline (dashed line) and Bolsa Familia Program nonbeneficiary families (solid line) in the crude cohort, Brazil,
2007–2014. A) Overall; B) leprosy high-burden municipalities; C) leprosy low-burden municipalities. In the matched cohort: D) overall; E) leprosy
high-burden municipalities; F) leprosy low-burden municipalities, according to follow-up time.
(Web Table 7). Inverse probability of treatment weighting
also generated similar estimates to the primary analysis,
suggestive of slightly lower leprosy incidence among BFP
beneficiary families (IRRPoisson = 0.95, 95% CI: 0.90, 1.00)
and stronger point estimates among cases with disabilities
(IRRPoisson = 0.87, 95% CI: 0.79, 0.96) (Web Table 8).
The complete-case analysis included 2,695,543 (63%) of
the original BFP beneficiary families and yielded results
similar to the primary analysis (IRRPoisson = 0.99, 95%
CI: 0.90, 1.10) (Web Table 9). When considering the same
number of family-years at risk for each matched pair or
restricting the follow-up to 2 years, we also obtained similar
or more extreme point estimates (Web Table 10 and Web
Table 11).
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Table 1. Description of Nonbeneficiary and Beneficiary Families of the Bolsa Familia Program (n = 12,949,730) Within 6 Months of Registration
in the 100 Million Brazilian Cohort, Brazil, 2007–2014
Social and Demographic Variable
Non-BFP (8,621,100) BFP (4,328,630)
No. % Median (IQR) No. % Median (IQR) P Valuea
Head-of-family characteristics
Age, years 40.2 (26.1–59.2) 32.6 (26.4–42.1) <0.001
Sex <0.001
Male 4,017,128 46.6 1,699,124 39.3
Female 4,603,972 53.4 2,629,506 60.7
Ethnicity <0.001
White 2,910,212 33.8 1,222,972 28.3
Black 625,762 7.3 389,069 9.0
Asian 43,379 0.5 18,047 0.4
Mixed/Brown 4,566,436 53.0 2,465,304 57.0
Indigenous 19,571 0.2 51,036 1.2
Missing 455,740 5.3 182,202 4.2
Literacy <0.001
Yes 7,364,320 85.4 3,875,678 89.5
No 1,220,161 14.2 422,482 9.8
Missing 36,619 0.4 30,470 0.7
Educationb <0.001
Primary school or less 2,495,387 28.9 1,090,961 25.2
Junior high school 2,069,347 24.0 1,387,715 32.1
High school 2,055,301 23.8 990,945 22.9
Missing 2,001,065 23.2 859,009 19.8
Occupation <0.001
Currently not working 3,720,000 43.1 1,995,758 46.1
Working 3,996,326 46.4 1,773,206 41.0
Missing 904,774 10.5 559,666 12.9
Household characteristics
Region of residence <0.001
North 890,499 10.3 558,683 12.9
Northeast 2,810,584 32.6 1,333,410 30.8
Southeast 2,969,267 34.4 1,777,094 41.1
South 1,112,028 12.9 357,311 8.3
Midwest 838,722 9.7 302,132 7.0
Area of residence <0.001
Urban 7,055,818 81.8 3,548,224 82.0
Rural 1,555,317 18.0 762,014 17.6
Missing 9,965 0.1 18,392 0.4
Leprosy high-burden municipality
No 6,029,977 69.9 2,460,514 56.8
Yes 2,591,123 30.1 1,868,116 43.2
Table continues
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Table 1. Continued
Social and Demographic Variable
Non-BFP (8,621,100) BFP (4,328,630)
No. % Median (IQR) No. % Median (IQR) P Valuea
Type of household <0.001
Private 7,435,902 86.3 3,630,445 83.9
Shared and informal housing 342,213 4.0 174,306 4.0
Missing 842,985 9.8 523,879 12.1
Construction material <0.001
Bricks/cement 6,894,374 80.0 3,402,241 78.6
Wood, other vegetal materials 1,436,989 16.7 794,292 18.3
Missing 289,737 3.4 132,097 3.1
Water supply <0.001
Public network (tap water) 6,541,878 75.9 3,120,429 72.1
Well, natural sources or other 1,789,487 20.8 1,076,099 24.9
Missing 289,735 3.4 132,102 3.1
Electricity <0.001
Electricity with counter 7,579,449 87.9 3,528,588 81.5
Electricity without counter or
no electricity
751,916 8.7 667,939 15.4
Missing 289,735 3.4 132,103 3.1
Sewage <0.001
Public network or septic tank 5,599,038 64.9 2,769,506 64.0
Homemade septic tank, ditch, or
other
2,533,943 29.4 1,305,835 30.2
Missing 488,119 5.7 253,289 5.9
Waste <0.001
Public collection system 6,898,397 80.0 3,430,663 79.3
Burned, buried, outdoor disposal,
or other
1,432,970 16.6 765,868 17.7
Missing 289,733 3.4 132,099 3.1
Basic servicesc <0.001
All adequate 4,669,921 54.2 2,146,962 49.6
1 inadequate 1,832,776 21.3 935,173 21.6
2 or 3 inadequate 799,949 9.3 486,692 11.2
All inadequate 830,326 9.6 506,507 11.7
Missing (all) 488,128 5.7 253,296 5.9
Family members 2 (1–3) 3 (2–4) <0.001
Residents per room 0.5 (0.3–0.8) 0.8 (0.5–1.0) <0.001
No. of children <18 years old 0 (0–1) 1 (1–2) <0.001
No. of elders >60 years old 0 (0–0) 0 (0–0) <0.001
Family income, BRL 465 (110–724) 150 (30.0–300.0) <0.001
Per capita income, BRL 177.7 (50–428.449) 50.0 (11.4–90.0) <0.001
Abbreviations: BFP, Bolsa Familia Program; BRL, Brazilian real; IQR, interquartile range.
a Two-tailed t test used for comparison of continuous variables and Pearson χ2 for categorical variables; missing data were considered a
category.
b Primary school or less: ≤5 years of education; junior high school: 6–9 years of education; high school: ≥10 years of education.
c Basic services: water supply, electricity, sewage, and waste.
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95% CI IRRMHb 95% CI IRRPoissonc 95% CI
Brazil overall
All new casesd 9,886 14.84 14.50, 15.18 15.48 14.91, 16.07 0.96 0.92, 1.00 0.97 0.90, 1.04
Grade 0 6,371 9.65 9.38, 9.93 9.73 9.28, 10.20 0.99 0.94, 1.05 1.00 0.92, 1.10
Grade 1 or 2 disabilities 2,534 3.74 3.57, 3.92 4.13 3.84, 4.45 0.91 0.83, 0.99 0.92 0.80, 1.05
Paucibacillary cases 4,022 6.09 5.87, 6.31 6.15 5.79, 6.52 0.99 0.92, 1.06 0.99 0.89, 1.10
Multibacillary cases 5,860 8.74 8.48, 9.00 9.33 8.89, 9.79 0.94 0.88, 0.99 0.96 0.87, 1.05
Leprosy high-burden municipalitiese
All new casesf 5,394 18.97 18.38, 19.58 22.26 21.17, 23.40 0.85 0.80, 0.90 0.86 0.77, 0.96
Grade 0 3,620 12.99 12.50, 13.49 14.19 13.33, 15.11 0.92 0.85, 0.98 0.91 0.80, 1.04
Grade 1 or 2 disabilities 1,251 4.29 4.01, 4.58 5.50 4.97, 6.08 0.78 0.69, 0.88 0.79 0.65, 0.97
Paucibacillary cases 2,415 8.43 8.04, 8.84 10.16 9.44, 10.94 0.82 0.76, 0.91 0.82 0.68, 0.98
Multibacillary cases 2,978 10.54 10.10, 11.00 12.09 11.29, 12.94 0.87 0.81, 0.94 0.89 0.77, 1.02
Leprosy low-burden municipalitiesg
All new casesh 4,578 11.82 11.43, 12.76 12.08 11.43, 12.76 0.98 0.92, 1.05 0.99 0.90, 1.09
Grade 0 2,746 7.22 6.92, 7.55 6.90 6.41, 7.42 1.05 0.96, 1.14 1.06 0.94, 1.20
Grade 1 or 2 disabilities 1,319 3.35 3.14, 3.57 3.64 3.30, 4.03 0.92 0.82, 1.03 0.93 0.79, 1.11
Paucibacillary cases 1,672 4.39 4.15, 4.64 4.22 3.85, 4.63 1.04 0.93, 1.16 1.04 0.89, 1.21
Multibacillary cases 2,903 7.42 7.11, 7.75 7.85 7.34, 8.41 0.95 0.87, 1.02 0.96 0.86, 1.09
Abbreviations: BFP, Bolsa Familia Program; CI, confidence interval; IR, incidence rate; IRR, incidence rate ratio; MH, Mantel-Haenszel.
a For n = 8,545,694 families; family-years at risk = 23,467,162.1; person-years at risk = 65,878,418.7.
b IRR estimated using Mantel-Haenszel method.
c IRR estimated using Poisson regression adjusting for income (continuous) and including robust standard errors clustered by family.
d In the stratified analysis, cases missing grade of disabilities at diagnosis (n = 981) or operational classification (n = 4) were censored at
the time the leprosy case occurred.
e For n = 3,674,130 families; family-years at risk = 9,707,927; person-years at risk = 27,235,798.9.
f In the stratified analysis, cases missing grade of disabilities at diagnosis (n = 523) or operational classification (n = 1) were censored at the
time the leprosy case occurred.
g For n = 4,871,424 families; family-years at risk = 13,719,482.8; person-years at risk = 38,493,252.5.
h In the stratified analysis, missing in grade of disabilities at diagnosis (n = 513) or operational classification (n = 3) were censored at the
time the leprosy case occurred.
DISCUSSION
This study investigated the impact of the Brazilian CCT
program on new-case detection of leprosy in a subset of the
100 Million Brazilian Cohort, which included 31.6 million
individuals from over 12.9 million families. Our findings
suggested that BFP was associated with lower incidence
of leprosy among families living in high-burden municipal-
ities for the disease in Brazil. We also obtained stronger
point estimates for the association between BFP and lower
incidence of paucibacillary forms and leprosy-associated
disabilities. These findings underscore the potential value of
CCTs for the control of leprosy in low- and middle-income
countries.
Our results indicated that families enrolled in the BFP
between 2007 and 2014 who resided in high-burden munic-
ipalities for leprosy had a 14% lower leprosy familial detec-
tion rate relative to nonbeneficiary families. These results
point to a similar magnitude of the association between BFP
and leprosy risk to that previously described in ecological
studies (14, 24). These ecological studies have reported a
15% lower leprosy new-case detection rate in the general
population and in children under 15 years of age in Brazilian
municipalities with high BFP coverage (≥48% coverage)
compared with municipalities with low coverage (<28%)
(14, 24). Additionally, our study suggests that BFP is asso-
ciated with fewer leprosy cases with PB presentations and
among cases with disabilities, although point estimates were
consistent across the other clinical presentations (i.e., MB
forms and cases without disabilities). Due to the impor-
tance of reducing leprosy and related disabilities, these find-
ings are of particular relevance to leprosy-control strategies
(2, 25).
CCTs are designed to have both short- and long-term
impacts on beneficiary families (26). By following families
for up to 7.5 years, our study provides new evidence that
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the association between BFP and lower leprosy incidence
was more prominent after a minimum of 2 years in the
program. The delayed association of the BFP could be
partially explained by the chronic nature of leprosy, which
has an incubation period of up to 10 years (27). It is plausible
that in the short term, BFP could increase food availabil-
ity and bolster host immunity, while cumulative exposure
to BFP could influence leprosy risk through longer-term
mediators, such as education, crowding, and other social
determinants of health (4, 11, 28). Stronger point estimates
for the association between BFP and incidence of PB leprosy
forms and leprosy-associated disabilities in high-burden lep-
rosy municipalities deserve further consideration. Because
leprosy-associated disabilities can be prevented by early
detection, enhanced health-care utilization rates among ben-
eficiary families could mediate the observed lower incidence
of cases with disabilities (11). Nevertheless, there is poor
knowledge of the factors that mediate different immune
response in PB and MB leprosy that could explain why
receiving BFP is associated with more pronounced asso-
ciation with lower PB leprosy forms in comparison with
MB forms. Also, increased access to health care among
beneficiary families might increase leprosy detection, and it
is therefore likely that our results represent an underestimate
of the causal effect of BFP on leprosy incidence in Brazil.
Although further research on the underlying mechanism by
which BFP affects leprosy risk in high-burden municipalities
is warranted, our results indicate that CCTs might have the
greatest impact in scenarios where individuals face a higher
and less heterogeneous disease risk (29).
The strengths and limitations of this study warrant con-
sideration. The 100 Million Brazilian Cohort is a power-
ful resource of sociodemographic information covering the
poorest half of the Brazilian population. Although previous
studies have evaluated the association between BFP and
leprosy or tuberculosis incidence in Brazil at the ecological
level (14, 15), this is the first study to use linked administra-
tive data to study the potential impact of a nationwide cash
transfer program on infectious disease incidence at the indi-
vidual level. Further, because leprosy is a rare disease, the
large size of the analytical cohort provided unprecedented
power to evaluate the associations between BFP and leprosy,
as well as its understudied clinical manifestations. Finally,
our analysis remained consistent, with similar point esti-
mates in all sensitivity analyses conducted, including inverse
probability of treatment weighting and restricted follow-
up times. However, our study is also subject to limitations.
First, although SINAN has national coverage, selection bias
might have arisen due to the suboptimal linkage between
the leprosy registry and the cohort baseline. This might
be explained by potential heterogeneity in the quality of
leprosy notification across Brazil, given that individuals of
mixed ethnicity and those living in the North and Northeast
regions of the country appeared to be underrepresented
among linked leprosy cases. Second, by defining exposure
status at 6 months, we might have missed a very short-term
impact of BPF participation in increasing leprosy diagnosis.
Finally, residual confounding (e.g., distance to health clinics
and/or access to primary health care) remains a concern even
though key sociodemographic risk markers for leprosy were
included in our propensity scores (4). Because this is a quasi-
experiment, we are cautious regarding our causal claims.
Nevertheless, given that leprosy prevalence is low and the
incubation period is long, as well as the nature of BFP as a
nationwide social intervention, it would be very unrealistic
to conceive a randomized control trial in this context.
This study has shown that the low-cost BFP (i.e., costing
<0.4% of the Brazilian GDP in 2007) is associated with
a significant reduction of leprosy in high-burden settings,
including cases with grade-2 disabilities that are the focus
of the WHO Global Leprosy Strategy 2016–2020 (2). We
hypothesize that CCTs might reduce infectious disease mor-
bidity, in part, by addressing some of the underlying deter-
minants of health, such as poverty, education, health-care
access, and nutrition (5, 7, 28, 30, 31). A hundred years
ago, it was stated that leprosy can be controlled with social
development (32). Now we have scientifically demonstrated
that social policies, such as BFP, could be a pillar for leprosy
control, and perhaps contribute to its elimination. Although
BFP has nationwide coverage, further efforts should be made
to scale the program up to serve poor families that are
just above the program eligibility threshold and living in
municipalities with high leprosy risk. In conclusion, these
findings indicate that relatively small cash transfer payments
undertaken as part of long-term investment in social policies
might have an important role in the control of a poverty-
driven disease like leprosy.
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